- Home
- LDWY vs EVOK Comparison
LDWY vs EVOK Comparison
Compare LDWY & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- EVOK
- Stock Information
- Founded
- LDWY 1990
- EVOK 2007
- Country
- LDWY United States
- EVOK United States
- Employees
- LDWY N/A
- EVOK N/A
- Industry
- LDWY Advertising
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- EVOK Health Care
- Exchange
- LDWY Nasdaq
- EVOK Nasdaq
- Market Cap
- LDWY 9.2M
- EVOK 4.2M
- IPO Year
- LDWY 1991
- EVOK 2013
- Fundamental
- Price
- LDWY $5.07
- EVOK $5.05
- Analyst Decision
- LDWY
- EVOK
- Analyst Count
- LDWY 0
- EVOK 0
- Target Price
- LDWY N/A
- EVOK N/A
- AVG Volume (30 Days)
- LDWY 4.1K
- EVOK 7.2M
- Earning Date
- LDWY 08-18-2025
- EVOK 08-12-2025
- Dividend Yield
- LDWY N/A
- EVOK N/A
- EPS Growth
- LDWY N/A
- EVOK N/A
- EPS
- LDWY N/A
- EVOK N/A
- Revenue
- LDWY $42,183,000.00
- EVOK $11,594,083.00
- Revenue This Year
- LDWY N/A
- EVOK $57.82
- Revenue Next Year
- LDWY N/A
- EVOK $59.12
- P/E Ratio
- LDWY N/A
- EVOK N/A
- Revenue Growth
- LDWY 425.12
- EVOK 89.89
- 52 Week Low
- LDWY $3.02
- EVOK $1.94
- 52 Week High
- LDWY $5.53
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- LDWY 53.73
- EVOK 63.11
- Support Level
- LDWY $4.10
- EVOK $5.74
- Resistance Level
- LDWY $5.39
- EVOK $9.88
- Average True Range (ATR)
- LDWY 0.31
- EVOK 0.56
- MACD
- LDWY -0.00
- EVOK 0.34
- Stochastic Oscillator
- LDWY 75.19
- EVOK 36.43
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.